Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) regularly issues news and updates that reflect its focus on better health outcomes for people with complex conditions and on specialty care solutions for payers and providers. Company news often highlights developments in oncology and other complex specialties, financial performance, strategic transactions and leadership changes.
Investors and industry observers following EVH news can expect recurring coverage of quarterly and annual financial results, including revenue and adjusted EBITDA metrics and management commentary on demand for complex specialty care solutions. Evolent frequently reaffirms or updates its financial guidance through press releases and related 8-K filings, and schedules conference calls and webcasts to discuss these results.
Evolent’s news flow also features clinical and partnership initiatives. For example, the company has announced a national partnership with American Oncology Network to introduce a model for cancer care that seeks to improve quality and affordability while reducing reliance on prior authorization. This model incorporates quality initiatives, AI-driven clinical insights through the MiBA analytics platform, payment innovation, and care navigation programs that use a cancer care management platform to support patients.
Corporate and capital markets announcements form another key part of EVH news. Recent items include the pricing and issuance of 4.50% convertible senior notes due 2031, repurchases of existing convertible notes and Class A common stock, and amendments to credit agreements and commitment letters for incremental financing facilities. Evolent also publishes updates on strategic portfolio actions, such as the divestiture of its value-based primary care business, Evolent Care Partners, to Privia Health Group, Inc.
Governance and leadership updates appear in the news as well, including appointments to executive roles, changes in the Chief Financial Officer position, and board retirements and appointments. For readers tracking EVH, this news page offers an ongoing view into how the company communicates its financial performance, specialty care initiatives, capital structure decisions and organizational evolution.
New Century Health (NCH) reported that its partner, Cancer Care Specialists (CCSI) of Illinois, earned nearly $3.6 million from Medicare through the Oncology Care Model (OCM). This payment reflects CCSI's success in reducing care costs while achieving quality targets for Medicare beneficiaries. Per-beneficiary costs were 8% below Medicare's benchmark, with high scores in patient experience and lower hospital utilization rates. NCH aims to improve patient outcomes and reduce expenses through effective oncology management and a focus on value-based care.
Evolent Health, Inc. (NYSE: EVH) announced participation in two upcoming investor conferences. Chief Financial Officer John Johnson and Vice President of Investor Relations Seth Frank will present at the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 9:10 a.m. ET, and at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022, at 9:00 a.m. ET. Live audio webcasts will be available on Evolent's investor relations website, with replays accessible shortly after the events.
Evolent Health (NYSE: EVH) reported Q4 and full-year financial results for 2021, showcasing GAAP revenue of $248.4 million, a slight increase of 0.7% year-over-year. In contrast, full-year revenue fell by 1.8% to $908.0 million. Notably, revenue excluding divested assets grew by 39.7% and 36.7% for Q4 and the full year, respectively. Despite a net loss of $(5.6) million in Q4 and $(37.6) million for 2021, Evolent achieved an Adjusted EBITDA of $24.3 million for Q4 and $66.3 million for the year. The company also announced new partnerships, enhancing its service delivery.
Summary not available.
Evolent Health (NYSE: EVH) has announced it will disclose its fourth quarter and full year 2021 operating results on February 23, 2022, after market close. Following the release, a conference call is scheduled at 5:00 p.m. Eastern Time. Participants can access the call by dialing 855.940.9467 or 412.317.6034 for international listeners, referencing the "Evolent Health call". An audio playback will be available on the company's investor relations website for one week after the event.
Evolent Health (NYSE: EVH) announced a partnership with PCG Consulting Group to establish a customer contact team in Cook County, Illinois, serving over 400,000 Medicaid members. This collaboration aims to enhance diversity and support minority communities. PCG, with 79% of its employees from underserved areas, provides crucial administrative and clinical services. The initiative aligns with Evolent's commitment to health equity and improving member experiences, particularly for Black and African American individuals in the area. The partnership is part of Evolent's broader strategy to promote diversity and community engagement.
Evolent Health (NYSE: EVH) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 4:30 p.m. ET. CEO Seth Blackley and CFO John Johnson will participate in the virtual event. Investors can access a live audio-only webcast on Evolent's website, with a replay available shortly after the event. Evolent Health provides clinical and administrative solutions aimed at improving health care affordability and efficiency, and it serves a nationwide base of healthcare payers and providers.
Evolent Health, Inc. (NYSE: EVH) has appointed Seth R. Frank as the new Vice President of Investor Relations, effective immediately. Reporting to CFO John Johnson, Frank will enhance the company's investor relations strategy and engagement with the investment community. He brings extensive experience from roles at Hanger, Inc. and Allscripts, along with a background as an equity analyst. This strategic appointment aims to boost investor knowledge of Evolent's operations and reinforce its commitment to delivering long-term shareholder value.
Evolent Health, Inc. (NYSE: EVH) announced that CFO John Johnson will lead a panel titled "Evolent Health Spotlight: New Century Health - Oncology Care Reimagined" on November 18, 2021, from 12-1 pm ET. The panel will include physicians from New Century Health, a subsidiary of Evolent, and partners discussing advancements in oncology care. Interested participants can register and access the event's live webcast via the company's website. The session will last approximately 60 minutes, including a Q&A segment. A replay will be available on the investor relations page afterward.
Evolent Health (NYSE: EVH) announced that CEO Seth Blackley and CFO John Johnson will attend the Piper Sandler 33rd Annual Healthcare Conference on December 1, 2021. The company specializes in clinical and administrative solutions aimed at enhancing health care quality while reducing costs. Evolent is recognized for its innovative contributions to population health management and has received national accolades for its workplace environment. For more information, visit evolenthealth.com.